Who
James DArecca
Director
Company insider
Files Form 4 as: Director, Prestige Consumer Healthcare; EVP, Chief Financial Officer, Haemonetics; Chief Financial Officer, TherapeuticsMD; SVP Chief Accounting Officer, Allergan.
In numbers
- Trades disclosed
- 78
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $81K
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 9 May 2014
- Last trade
- 4 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Aug 2026filed 5 Aug 2026 | PBH Prestige Consumer HealthcareHousehold & Personal Care | SEC FORM 4 Code A | —2,981 at $0.00 | filing |
| 4 Aug 2026filed 5 Aug 2026 | PBH Prestige Consumer HealthcareHousehold & Personal Care | SEC FORM 4 Code A | —2,981 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $141K2,505 at $56.29 | filing |
| 15 May 2026filed 19 May 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —29,312 | filing |
| 15 May 2026filed 19 May 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $141K2,505 at $56.29 | filing |
| 15 May 2026filed 19 May 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —29,312 | filing |
| 1 May 2026filed 5 May 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $39K655 at $59.26 | filing |
| 1 May 2026filed 5 May 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $39K655 at $59.26 | filing |
| 5 Aug 2025filed 6 Aug 2025 | PBH Prestige Consumer HealthcareHousehold & Personal Care | SEC FORM 4 Code A | —2,094 at $0.00 | filing |
| 30 May 2025filed 3 Jun 2025 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —12,221 at $0.00 | filing |
| 30 May 2025filed 3 Jun 2025 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $407K5,864 at $69.38 | filing |
| 16 May 2025filed 20 May 2025 | HAE Haemoneticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —15,396 at $0.00 | filing |
| 16 May 2025filed 20 May 2025 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —7,111 | filing |
| 16 May 2025filed 19 May 2025 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $88K1,246 at $70.31 | filing |
| 15 May 2025filed 19 May 2025 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $43K622 at $69.38 | filing |
| 2 May 2025filed 5 May 2025 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $42K654 at $63.85 | filing |
| 6 Aug 2024filed 7 Aug 2024 | PBH Prestige Consumer HealthcareHousehold & Personal Care | SEC FORM 4 Code A | —2,202 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | HAE Haemoneticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —9,756 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —4,439 | filing |
| 16 May 2024filed 17 May 2024 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code F | $33K351 at $94.80 | filing |
News
TherapeuticsMD (NASDAQ:TXMD) vs. Addex Therapeutics (NASDAQ:ADXN) Head to Head ComparisonTXMD · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name James DArecca; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.